Literature DB >> 18206537

Copy number alterations of the H2AFX gene in sporadic breast cancer patients.

Niloo Srivastava1, Sailesh Gochhait, Pawan Gupta, Rameshwar N K Bamezai.   

Abstract

In addition to being a structural component of chromatin, histone H2AX also has an important role in preserving genetic integrity. The histone H2AFX gene maps to the chromosome region 11q23.2 approximately 11q23.3 that is deleted in most human cancers. Mouse model studies also have clearly shown its involvement in tumorigenesis in a dosage-dependent manner. Therefore, in this study, DNA from 65 paired sporadic breast cancer tissues was systematically screened for gene mutations and changes in gene copy numbers. Although whole H2AFX gene scans showed an absence of mutation in the studied samples, the H2AFX gene copy number was altered in 37% of tumor samples. Furthermore, a twofold reduction in gene copy number in the MCF7 cell line strongly suggests the involvement of H2AFX alteration in breast carcinogenesis. Analysis of clinicopathologic association revealed a convincing correlation with positive estrogen/progesterone receptor status. To our knowledge, this is the first report of a change in H2AFX gene copy number in human cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206537     DOI: 10.1016/j.cancergencyto.2007.09.024

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  20 in total

1.  Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.

Authors:  Weiwei Fan; Keke Zhou; Yingjie Zhao; Wenting Wu; Hongyan Chen; Li Jin; Gong Chen; Jinlong Shi; Qingyi Wei; Tianbao Zhang; Guhong Du; Ying Mao; Daru Lu; Liangfu Zhou
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

Review 2.  Histone variants: emerging players in cancer biology.

Authors:  Chiara Vardabasso; Dan Hasson; Kajan Ratnakumar; Chi-Yeh Chung; Luis F Duarte; Emily Bernstein
Journal:  Cell Mol Life Sci       Date:  2013-05-08       Impact factor: 9.261

3.  Possible novel roles of poly(rC)-binding protein 1 in SH-SY5Y neurocytes: an analysis using a dynamic Bayesian network.

Authors:  Li-Rong Huo; Jian-Tao Liang; Jun-Hua Zou; Lan-Ying Wang; Qi Li; Xiao-Min Wang
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

4.  Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.

Authors:  Xiaoli Yang; Peng Zou; Jun Yao; Dong Yun; Huimin Bao; Ruyun Du; Jing Long; Xian Chen
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

5.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

6.  Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.

Authors:  Cecilia Williams; Luisa Helguero; Karin Edvardsson; Lars-Arne Haldosén; Jan-Ake Gustafsson
Journal:  Breast Cancer Res       Date:  2009-05-08       Impact factor: 6.466

Review 7.  H2AX: functional roles and potential applications.

Authors:  Jennifer S Dickey; Christophe E Redon; Asako J Nakamura; Brandon J Baird; Olga A Sedelnikova; William M Bonner
Journal:  Chromosoma       Date:  2009-08-26       Impact factor: 4.316

8.  Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.

Authors:  Angela Fusello; Julie Horowitz; Katherine Yang-Iott; Brenna L Brady; Bu Yin; Marta A W Rowh; Eric Rappaport; Craig H Bassing
Journal:  Cell Cycle       Date:  2013-08-08       Impact factor: 4.534

Review 9.  Defining the chromatin landscape in demyelinating disorders.

Authors:  Jimmy Long Huynh; Patrizia Casaccia
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

10.  Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Brad Love; Darrell L Ellsworth; Craig D Shriver
Journal:  Pathol Oncol Res       Date:  2009-02-05       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.